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Structures of Two Streptococcal Superantigens
Bound to TCR  Chains Reveal Diversity in the
Architecture of T Cell Signaling Complexes
tide binding groove and interact with TCR V domains,
resulting in the stimulation of a large fraction (up to
5%–20%) of the T cell population. SAGs have been impli-
cated in the pathogenesis of a number of human dis-
eases, including toxic shock syndrome, food poisoning
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two distinct, yet overlapping, binding sites. This resultsmodes could also contribute to the structural hetero-
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of the MHC molecule may be less variable. In thesecoupled with the recently determined SpeC-HLA-DR2a
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in complex with HLA-DR2a [13] and SEH bound to HLA-signaling complex that precludes direct TCR-MHC in-
DR1 [14], both SAGs coordinate a zinc ligand and in-teractions. Thus, highly efficient T cell activation may
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Further complicating the structural description of SAG-TCR ligation.
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have been determined. In all of these complexes, the Results
SAG interacts predominantly with residues from the sec-
Overview of the SpeC-hV2.1ond complementarity-determining region (CDR2), the
and SpeA-mV8.2 Structuresthird framework region (FR3), and, to a lesser extent,
We have determined the structure of the complex be-the hypervariable region 4 (HV4) of the TCR  chain. The
tween SpeC, in which the histidine residue at positionorientations of SEC2, SEC3, and SEB, when bound to
35 was mutated to an alanine (SpeC H35A) and thethe TCR  chain, are virtually identical.
human V2.1D2.1J2.3C2 TCR chain, hV2.1. WhileA structural model of the TCR-SEB-MHC ternary com-
the SpeC wild-type and mutant proteins bind the TCRplex, produced by assembling the various bimolecular
 chain with similar affinities (KD  2  105 M; data notstructures involved, suggests that SEB acts as a wedge
shown), only the SpeC variant crystallized with hV2.1,between the MHC  chain and the TCR  chain [19],
much as in the case of the SpeC-HLA-DR2a complexcausing a rotation of the TCR about the interface be-
[13]. The structure of the complex was determined bytween the V CDR2 loop and the MHC   helix in
molecular replacement using wild-type SpeC [10] as athe TCR-peptide/MHC complex [20, 21] and effectively
search model, combined with manual chain tracing ofpreventing the antigenic peptide and most of the CDR
TCR  chains in 2Fo  Fc electron density maps calcu-loops from making any specific interactions within the
lated with phases from four SpeC molecules in the asym-ternary complex. This model also predicts that at least
metric unit (see Experimental Procedures). There aresome contacts between the MHC  and TCR  chains
four SpeC molecules and two TCR  chain moleculesremain. Due to the variability in complex formation be-
per asymmetric unit in the final model. Although non-tween SAGs and MHC molecules, the TCR-SEB-MHC
crystallographic symmetry, crystal packing constraints,ternary complex model cannot, by definition, represent
and electron density allude to the presence of two addi-accurately the structures of TCR-SAG-MHC complexes
tional TCR  chain molecules in the crystal that formfor those SAGs that bind differently to MHC, even if
similar heterodimeric complexes with the two unboundthere exists only a single binding mode for SAG-TCR
SpeC molecules as those that are bound (in the finalinteractions. Although the SAG-TCR  chain complex
model), they were not built into the final model becausestructures determined to date have revealed a single
their inclusion did not improve the overall refinementbinding mode, different SAGs bind to distinct groups of
statistics. The SpeC mutation site, H35A, is located inTCR V subsets, with certain SAGs having the ability to
neither the -SpeC nor the SpeC-SpeC interface in thebind many different V domains, while others are more
crystal. Crystallographic data collection and structurerestricted in their V domain specificity. Thus, it is likely
refinement statistics are summarized in Table 1. Al-that there exist multiple SAG-TCR binding modes. With
though the data integrates well to a nominal resolution ofvariability in complex formation on both the MHC and
3.0 A˚, as shown by the statistics of the highest resolutionTCR sides of the SAG crosslinking reaction, the number
shell, 3.11–3.0 A˚, diffraction intensities beyond this reso-of distinct ternary complexes could be quite large.
lution degraded precipitously to such an extent thatTo better understand the structural basis for the acti-
the inclusion of any higher diffraction data would onlyvation of T cells by bacterial SAGs, we have determined
increase uncertainty in the model. A large degree ofthe structures of two SAGs from Streptococcus pyo-
disorder in the crystal radiates from the interface of thegenes, SpeA and SpeC, in complex with their specific
first -SpeC complex (as evidenced by the increasinglyTCR  chain ligands, mouse V8.2 (mV8.2) and human
higher B factor values for peripheral molecules) and isV2.1 (hV2.1), respectively. Together, SpeA and SpeC
the likely reason for our inability to model all of the TCRare associated with nearly all cases of streptococcal
 chain molecules and the relatively high R factor values.
toxic shock syndrome [22]. While the structure of the
While this disorder results in an unavoidably underdeter-
SpeA-mV8.2 complex is very similar to structures of
mined overall crystal structure, the first -SpeC complex
this TCR  chain complexed with SAGs from Staphylo-
in the asymmetric unit is well ordered throughout, and,
coccus aureus [18, 19], differences in the number and thus, all further analysis and discussion is limited to
types of intermolecular contacts in the common binding this particular binary complex. Figure 1A shows electron
interface, as well as the involvement of the CDR1 loop, density from a composite annealed omit map in this
distinguish the SpeA binding mode. The SpeC-hV2.1 -SpeC interface region, revealing well defined atomic
complex structure, conversely, reveals a completely dif- positions for both main chain and side chain atoms.
ferent set of SAG-TCR interactions, involving a much We also solved the structure of SpeA, in which a free
more extensive buried surface area and numerous spe- cysteine at position 90 has been mutated to a serine
cific interactions between SpeC residues and all three (SpeA C90S) complexed with the 14.3.d TCR  chain
of the TCR  chain CDRs, as well as HV4. Coupled with (mouse V8.2J2.1C1, mV8.2) in two forms, with and
the SpeC-HLA-DR2a complex structure [13], in which without zinc, since a potential zinc binding site for SpeA
SpeC binds to the high-affinity MHC  chain site, we has been described [23]. Although the wild-type and
provide an alternative model for TCR-SAG-MHC ternary mutant SpeA molecules bind TCR with similar affinities
complex formation bearing little resemblance to that of (KD  6  106 M; [24] and data not shown), attempts
SEB and show that wide variations are possible in the to crystallize the wild-type -SpeA complex in the pres-
specific geometry of TCR engagement by SAG-MHC ence of reducing agent resulted only in poorly diffracting
ligands that are nevertheless compatible with highly effi- crystals. Mutation of the free cysteine in SpeA allowed
cient T cell activation comparable to that by specific the growth of crystals in the absence of reducing agent
and resulted in significant improvement in diffractionpeptide/MHC complexes.
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Table 1. Crystal Data Collection and Structure Refinement Statitics
-SpeC -SpeA (apo) -SpeA (zinc-soaked)
Data Collection
Space group P21 P21 P21
Unit cell dimensions
a (A˚) 57.4 71.4 71.7
b (A˚) 146.8 83.3 83.7
c (A˚) 135.7 93.6 93.9
 () 98.6 91.7 91.7
Molecules per asymmetric unit 4 SpeC/4 hV2.1 2 SpeA/2 mV8.2 2 SpeA/2 mV8.2
Resolution (A˚) 3.0 2.8 2.5
Mosaicity () 0.4 0.6 0.5
Observations 158,446 80,520 115,588
Unique reflections 43,729 26,926 37,614
Completeness (%) 97.8 (96.5)a 99.1 (99.8) 96.7 (77.9)
Mean I/ (I) 16.0 (6.5) 9.6 (3.6) 10.3 (1.4)
Rsymb (%) 5.0 (20.7) 12.1 (37.3) 10.7 (48.1)
Refinement
Rworkc (%) 32.6 (35.7) 23.2 (39.7) 22.1 (32.0)
Rfreec (%) 33.5 (36.2) 27.8 (45.9) 26.2 (38.3)
Protein residues 1200 914 913
Water molecules 0 181 316
Zinc atoms 0 0 6
Average B factors
SpeC (1) 59.1 SpeA (1) 41.7 SpeA (1) 42.2
SpeC (2) 79.9 SpeA (2) 38.0 SpeA (2) 35.4
SpeC (3) 60.1 V (1) 26.6 V (1) 25.2
SpeC (4) 77.2 C (1) 53.8 C (1) 52.3
V (1) 79.7 V (2) 26.9 V (2) 24.6
C (1) 84.2 C (2) 52.7 C (2) 52.5
V (2) 108.2 H2O 29.9 H2O 34.5
C (2) 123.0 Zinc 53.1
Rms deviations from ideality
Bonds (A˚) 0.011 0.007 0.007
Angles () 1.99 1.34 1.28
Ramachandran plot statistics
Core (%) 62.5 84.7 85.6
Allowed (%) 28.0 14.2 13.5
Generous (%) 8.0 0.9 0.9
Disallowed (%) 1.5 0.2 0.0
a Values in parentheses correspond to the highest resolution shell (-SpeC, 3.11–3.00 A˚; -SpeA (apo), 2.9–2.8; -SpeA (zinc), 2.58–2.49).
b Rsym  |(Ihkl  I(hkl))|/(Ihkl), where I(hkl) is the mean intensity of all reflections equivalent to reflection hkl by symmetry.
c Rwork (Rfree)  ||Fo|  |Fc|/|Fo||, where Fc is the calculated structure factor; reflections used in test set include: -SpeC, 1846 reflections,
4.8%; -SpeA (apo), 1326 reflections, 4.9%; -SpeA (zinc), 1871 reflections, 4.8%.
quality. The structure of the complex was solved by Multiple Binding Modes for Complexes between
Bacterial SAGs and TCR  Chainsmolecular replacement using wild-type SpeA [23] and
the 14.3.d TCR  chain [25] as search models. Data The overall structures of the -SpeC and -SpeA com-
plexes (Figures 1B and 1D) show, as for the -SEC3 [18]collection and refinement statistics for both crystal
forms are shown in Table 1. Due to the better diffraction and -SEB [19] complexes, that residues in the cleft
between the large and small domains of both SAGsand refinement of the zinc-soaked crystals, all subse-
quent discussion of the -SpeA complex is limited to make intermolecular contacts with residues from both
the CDR loops and FRs of their respective TCR  chainthis form. Electron density from a composite annealed
omit map in the -SpeA interface is shown in Figure ligands. It is evident, though, that the -SpeC complex
involves a significantly larger number of interface resi-1C. As in the -SpeC complex, the SpeA mutation site,
C90S, is not involved in TCR  chain, or other crystal dues than does the -SpeA complex. Superposition of
the TCR  chains of the -SpeC, -SpeA, and -SEBcontact, interactions. None of the six zinc ions in the
zinc-soaked crystals are located in the -SpeA interface complex structures (Figure 2) reveals that SpeC inter-
acts with its TCR  ligand through an altered orientationor at the putative MHC class II binding site. A zinc atom
is present at the site predicted by Papageorgiou et al. relative to that used by SpeA or SEB. SpeC binds in a
more encompassing manner to the V domain than do[23], tetrahedrally coordinating SpeA residues Glu33,
Asp77, His106, and His110. The physiological role of SpeA (Figure 2A) and SEB (Figure 2B). Thus, while por-
tions of the main chain superimpose well at the topthis site, if any, is unknown.
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Figure 1. Structural Overview of the SpeC-hV2.1 and SpeA-mV8.2 Complexes
Final composite annealed omit electron density maps for part of the interface regions of (A) the SpeC-hV2.1 complex and (C) the SpeA-
mV8.2 complex, contoured at 1.5 . Structural overviews of (B) the SpeC-hV2.1 complex and (D) the SpeA-mV8.2 complex. Colors are as
follows for both complexes: SAG, yellow; TCR  chain, green; SAG interface residues, cyan; TCR  interface residues, red. Carbon atoms are
in yellow for the SAGs and in green for the TCR  chains. Nitrogen atoms, blue; oxygen atoms, red.
end of the interface along the side of the V domain, -SpeA, and -SEB complexes are 1818, 1324, and
1268 A˚2, respectively. The -SpeA and -SEB buriedcomprised mainly of FR residues for all of the complex
structures, SpeC extends around the apical region of surface areas fall within the range observed for antigen-
antibody complexes [26] but short of values definedthe V domain, comprised predominantly of CDR loops.
SpeA and SEB, conversely, bind mV8.2 in an essentially for TCR-peptide/MHC complexes [20, 21, 27, 28]. The
-SpeC complex, however, has a significantly largeranalogous orientation (Figure 2C), with contacts re-
stricted largely to the side of the V domain. buried surface, which is comparable to those of TCR-
peptide/MHC complexes.The solvent-excluded surface areas of the -SpeC,
Figure 2. SpeC Adopts a More Apical Position for Its Interaction with Its TCR  Chain Ligand Than Do Other Bacterial Superantigens
Superpositions of (A) the SpeA-mV8.2 (green) and SpeC-hV2.1 (yellow) complexes, (B) the SpeC-hV2.1 (yellow) and SEB-mV8.2 (red)
complexes, and (C) the SpeA-mV8.2 (green) and SEB-mV8.2 (red) complexes.
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Figure 3. Diverse TCR  Chain Molecular
Surface Burial by Bacterial Superantigens
Molecular surface of (A) hV2.1 buried by
SpeC, (B) mV8.2 buried by SpeA, and (C)
mV8.2 buried by SEB. Colors are as follows:
CDR1 buried molecular surface, red; CDR2
and associated FR buried molecular surface,
green; HV4 and associated FR buried molec-
ular surface, yellow; CDR3 buried molecular
surface, blue.
As shown in Figure 3, there exists not only a quantita- FR3 (Figures 3A and 3C). Surprisingly, SpeC was also
found to contact residues from the CDR1 and CDR3tive difference in the TCR  chain surface burial by these
three SAGs but also a number of qualitative distinctions. loops. Together, the hV2.1 residues buried by SpeC
upon complex formation comprise a large and contigu-SpeC contacts portions of the molecular surface of the
hV2.1 domain that have previously been shown to be ous molecular surface that extends from more than half-
way up the side of the V domain to the extreme bottominvolved in the interface of other SAG-TCR  chain com-
plexes, including residues from CDR2, HV4, FR2, and of the molecule. While the differences between the pat-
Structure
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terns of V molecular surface buried by SpeA and SEB in the disulfide loop of SpeA, the region of the two SAGs
that diverges the most structurally, due primarily to the(Figures 3B and 3C) are less extensive than between
SpeC and SEB, there are some notable differences in difference in length between this loop in SpeA and SEB
(10 and 19 residues, respectively). Glu94 and its counter-their binding modes. SpeA binding to mV8.2 results in
an extension of the molecular surface buried by SEB to part in SEB, Thr107, however, are positionally equivalent
when the V domains of the -SpeA and -SEB com-more apical regions of HV4 as well as to CDR1. There
are no significant differences in the structures of the V plexes are superimposed. Because the position and
conformation of the mV8.2 CDR1 loop is unchangeddomain bound by SpeA and SEB, except in the CDR3
loop. This region of the TCR  chain, however, makes between the two complexes, the hydrogen bond, which
is formed by SpeA Glu94 and not by SEB Thr107, iscontacts neither with SpeA nor SEB. Conversely, the
TCR  chain ligand of SpeC is structurally distinct from simply a result of the length of the side chain at this
position in the two SAGs, as both glutamic acid andthat bound by SpeA and SEB, particularly in its CDRs
(see below). The extended conformation of hV2.1 threonine residues have terminal oxygen atoms with
hydrogen bonding capabilities. The interfaces of SpeACDR3, which points directly toward the interface, con-
tributes at least partially to its involvement in SpeC bind- and SEB in complex with the CDR2/FR3 region of
mV8.2 are distinguished primarily by the quantity anding. Notwithstanding differences in V CDRs, there is a
significantly higher degree of envelopment of the hV2.1 quality of hydrogen bonds observed. SEB forms numer-
ous van der Waals interactions but only three hydrogensurface by SpeC than by SpeA and SEB of mV8.2, likely
due to a somewhat deeper and broader cleft between bonds, all between SEB side chain and mV8.2 main
chain atoms. In the -SpeA complex, there exists a simi-the large and small domains in SpeC compared to those
in SpeA and SEB (Figures 1 and 2). Subsequently, the lar number of van der Waals contacts, and the three
hydrogen bonds observed in the -SEB complex are-SpeC interface is characterized by a large number of
contacts involving all three mV2.1 CDR loops, HV4, retained by analogous residues in the -SpeA complex.
Five additional hydrogen bonds, several of which involveand associated FRs. These contacts are made to atoms
in CDR1 (19%), FR2 (3%), CDR2 (34%), FR3 (22%), HV4 mV8.2 side chain atoms, however, are observed in the
-SpeA complex. Interactions in the HV4/FR3 portion(13%), and CDR3 (9%). For the -SpeA complex, by
comparison, the CDR1, CDR2, FR3, and HV4 regions of the interfaces of the -SpeA and -SEB complexes
are nearly identical.account for 6%, 33%, 50%, and 11%, respectively, of
the total contacts to the SAG.
Unlike in the -SEB complex (Figure 4, right column),
Comparison of MHC Class II-Dependent T Cellwhere hydrogen bonds are made between SEB side
Signaling Complexeschain and TCR  main chain atoms [19], SpeC forms
A model of the MHC-SEB-TCR ternary complex hasnumerous specific hydrogen bonds and van der Waals
been constructed by superposition of the common ele-interactions with both main chain and side chain atoms
ments of the SEB-peptide/HLA-DR1 complex [11], theof hV2.1 (Figure 4, left column). CDR1 residues Gln28,
14.3.d TCR  chain-SEB complex [19], and the 2C Ala29, and Thr30 contact two discontinuous sets of resi-
TCR heterodimer [29]. In this model (Figure 5B), SEBdues from SpeC, Leu78/Asn79 and Arg45/Tyr49, through
acts as a wedge, essentially rotating the TCR about aa combination of van der Waals contacts and hydrogen
contact point between the MHC  subunit  helix andbonds. Specific hydrogen bonds between side chains
the TCR  chain CDR2 loop, relative to the HA 306–318from each molecule in the -SpeC complex are also
peptide/HLA-DR1-HA1.7 TCR complex [21] (Figure 5A).observed in the CDR2 portion of the interface. The O	
This effectively prevents the peptide and all of the CDRatom of Ser52a is sandwiched, through hydrogen bonds,
loops, except V CDR2, from making specific contactsby the side chains of SpeC residues Tyr15 and Arg181,
in the signaling complex. The interaction between resi-which are also responsible for other hydrogen bonds in
dues from the MHC  chain and the V CDR2 loop hasthis region of the interface. Two hydrogen bonds involv-
been confirmed by biochemical and mutational studiesing only main chain atoms are observed between His69
[30] in which positive binding cooperativity was ob-and Thr18 of hV2.1 and between Ala70 and Thr20 of
served when a ternary complex was formed betweenSpeC. The remainder of the interactions between SpeC
HLA-DR1, SEC3, and the 14.3.d TCR  heterodimerand the CDR2 portion of hV2.1 is comprised of van der
but was absent when a similar complex was formedWaals interactions. Interactions in the HV4/FR3 region
using only the 14.3.d TCR  chain. It is likely that SpeAof hV2.1 are similar in nature to those in the -SEB
crosslinks TCR and MHC in a manner analogous to SEBcomplex in that they are predominantly comprised of
or SEC3, since SpeA probably binds MHC class II at thevan der Waals interactions and hydrogen bonds to main
same low-affinity site as SEB [23], and, as discussedchain atoms, although they are much more numerous
above, the two toxins have very similar TCR bindingin the former. The long, protruding CDR3 loop of hV2.1
sites.points directly toward the SAG, contacting SpeC Asn79
Although no MHC-SpeC-TCR ternary complex struc-and producing several hydrogen bonds.
ture exists, the SpeC-TCR  chain complex presentedWhile SpeA and SEB interactions with mV8.2 have
here allows us to propose a structural model for thea high degree of similarity, there are a number of distinc-
MHC-SpeC-TCR ternary signaling complex, revealingtive features of their respective interfaces (Figure 4, mid-
that the crosslinking mechanism utilized by SpeC isdle and right columns). Most notable is the hydrogen
completely dissimilar to that of SEB. A model of thebond formed between the side chains of Asn28 of the
CDR1 loop of mV8.2 and Glu94 of SpeA. Glu94 resides MHC-SpeC-TCR ternary signaling complex produced
Diverse TCR Engagement by Bacterial Superantigens
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Figure 4. Intermolecular Contacts Resulting from Complexes of SpeC, SpeA, and SEB with Their Respective TCR  Chain Ligands
Intermolecular contacts made in the SpeC-hV2.1 complex (left column), the SpeA-mV8.2 complex (middle column), and the SEB-mV8.2
complex (right column). Contacts are further divided according to those made by the CDR1 loop, CDR2 loop and associated FR residues,
HV4 loop and associated FR residues, and CDR3 loop (from top to bottom, respectively). SAG molecule, yellow; TCR  chain, green. Hydrogen
bonds are represented by dotted lines, and van der Waals interactions are represented by dashed lines. Main chain and side chain atoms
not involved in intermolecular contacts have been omitted for clarity.
by superposition of the common elements of the SpeC- ble MHC-TCR contacts. When the MHC-SpeC-TCR
model is viewed in the two orientations shown (FiguresMBP 89–101 peptide/HLA-DR2a complex [13], the
-SpeC complex presented in this study, and the 2C  5C and 5D), it is apparent that the TCR in the MHC-
SpeC-TCR model is rotated, relative to the MHC-TCRTCR heterodimer [29] is shown in two orientations in
Figures 5C and 5D. Unlike the MHC-TCR crosslinking complex, about the horizontal axis by a similar amount
to that in the MHC-SEB-TCR model, but in the oppositemechanism of SEB, SpeC acts as a bridge between the
MHC and TCR molecules. This results in a displacement direction, and about the vertical axis by approximately
90. As for the MHC-TCR complex and the MHC-SEB-of the TCR away from its position in the MHC-TCR com-
plex (Figure 5A) and a complete disruption of any possi- TCR model, the carboxyl termini of the MHC and TCR
Structure
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Figure 5. Comparison of MHC Class II-Dependent T Cell Signaling Complexes
(A) The TCR-peptide/MHC complex [21].
(B) A model of the MHC-SEB-TCR ternary complex, produced by superposition of the common elements of the SEB-peptide/HLA-DR1 [11],
14.3.d TCR  chain-SEB [19], and the 2C  TCR complexes [29].
(C and D) Two views of the MHC-SpeC-TCR ternary complex model produced by the superposition of the SpeC-MBP 89–101 peptide/HLA-
DR2a complex [13], the -SpeC complex presented in this study, and the 2C  TCR complex [29]. In the first view (C), the MHC molecule
is approximately aligned with that in the MHC-TCR (A) and MHC-SEB-TCR (B) complexes. The second view of the MHC-SpeC-TCR complex
(D) is rotated by approximately 90 about the vertical axis. In all panels, the colors are as follows: MHC  chain, green; MHC  chain, blue;
antigenic peptide, gray; TCR  chain, orange; TCR  chain, red; SAG, yellow.
 and  chains (which enter their respective cell mem- CDR3 loops of TCR  chains are much more variable
in sequence and structure due the recombination ofbranes) in the MHC-SpeC-TCR model are aligned such
that this ternary signaling complex could easily be ac- V-D-J gene segments. Thus, SAGs such as SEC3
and SEB that depend only on the backbone conforma-commodated between two interacting cells. Although
the MHC-SpeC-TCR ternary complex is slightly ex- tion of one of the relatively invariable CDR loops will not
have a high V domain binding specificity.tended compared to the MHC-SEB-TCR complex, this
increase in intermembrane length is small compared to Clearly, the small sample size of available SAG-TCR
 complexes has hampered a comprehensive analysisthose that have been found to affect the conservation
of distance within the immunological synapse to such of these interactions. The structures presented here,
including SpeA complexed with the same 14.3.d TCR an extent that T cell activation is disrupted [31].
chain that has been used previously in SAG-TCR struc-
tural studies as well as SpeC complexed with a humanDiscussion
TCR  chain that has never before been characterized
structurally, expand the available database of complexPrevious crystal structures of SAG-TCR  chain com-
plexes [18, 19] have revealed only a single binding mode structures significantly, demonstrate that there exist
multiple binding modes for SAG-TCR interactions, andfor these types of interactions. Both SEC3 and SEB
bind to mV8.2 predominantly through contacts with help to elucidate the structural basis for V specificity
by SAGs.residues from CDR2, HV4, and their associated FRs.
Furthermore, all of the hydrogen bonds in these com- Relative to other SAGs, SpeC binds TCR  chains
in a highly specific manner, primarily activating humanplexes involve only main chain atoms of mV8.2, and,
thus, it has been proposed that their binding mechanism T cells bearing V2.1 [33]. While the -stranded core of
the hV2.1 domain is very similar to that of mV8.2, theis one of simple conformational dependence [18, 19].
We define conformationally dependent binding as inter- binding surface of hV2.1 presented to SpeC differs
significantly from that of the SpeA- and SEB-specificactions that rely predominantly on the protein backbone
atomic structure of the V domain, largely independent mV8.2 and is unique in relation to the structures of
other V domains. Several features of hV2.1 contributeof amino acid sequence, and, consequently, of side
chain structure. Structural variation in V domains is clearly to its specificity for SpeC. These include two
single amino acid insertions, one each in CDR1 andmainly restricted to its three CDR loops extending from
a common structural foundation, the framework region. CDR2, and an extended CDR3 loop.
The CDR1 insert (Phe27a) results in a semi-rigid-bodyEven the first two CDR loops, however, are not exces-
sively variable. A recent analysis of V gene segments movement of this loop away from its position in other V
domains and toward the SpeC molecule in the -SpeCand known atomic structures [32] estimates that 90 per-
cent of these gene segments have CDR1 and CDR2 structure. The consequence of this CDR1 rearrangement
is an average displacement of hV2.1 residues Gln28,loops of any of three known canonical structures each.
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Ala29, and Thr30 by 1.7 A˚ closer to SpeC, relative to -SpeC binding mode, and they may thus form further
distinct complexes with TCR.the positions of analogous residues of mV8.2 CDR1 in
the -SpeA complex. Without such a movement, the While there is some overlap in V binding specificity
between SpeA and SEB, namely mV8.2 and the homol-numerous hydrogen bonds and van der Waals interac-
tions between SpeC and these three hV2.1 residues ogous hV12.2 and hV14.1 [38, 39], SpeA is a much
more specific stimulator of T cells than SEB, which alsocould not be formed.
The CDR2 loop of hV2.1 possesses two noteworthy recognizes mV3, 7, 10, 11, and 17 and hV3, 5, 12, 13,
14, 15, 17, and 20 [2, 17]. At least part of the reason forstructural features. First, it has a single residue insert,
relative to other V domains, common only to hV2.1 this striking difference in V specificity can be deduced
from the -SEB and -SpeA complex structures. In theand hV4.1 and their mouse analogs, mV15.1 and
mV18.1 [34]. Additionally, this CDR2 loop has been former complex, all the hydrogen bonds between SEB
and V are formed between SEB side chain atoms andpredicted to have a noncanonical conformation [32], a
feature that is apparent in Figure 4, in relation to the V main chain atoms, such that SEB is able to bind a
variety of V domains whose corresponding main chainCDR2 loop of mV8.2. That the inserted residue in CDR2,
Ser52a, appears to be responsible for the most produc- atoms are at positions similar to those in mV8.2, largely
independent of side chains [19]. In the -SpeA complex,tive interactions in the-SpeC complex is not surprising,
considering that SpeC is highly specific for V domains by contrast, the majority of interface hydrogen bonds
involve side chain atoms from either, or both, the SAGthat share these rare CDR2 features [33]. The recent
development of SpeC vaccine toxoids that protected and V molecules, including a greater overall number
of hydrogen bonds (Figure 4, middle and right columns).rabbits from streptococcal toxic shock syndrome in-
cluded mutation of Tyr15 to alanine [35], which presum- Thus, SpeA seems to require some V sequence speci-
ficity that restricts its reactivity beyond the simple con-ably abolishes their T cell stimulating capacities, indi-
rectly supporting the energetic importance of the formation dependence required by SEB. The increased
number of intermolecular interactions in the -SpeAelectrostatic interactions formed between SpeC and
Ser52a of hV2.1. It is interesting to note that, while complex versus the-SEB complex may also explain the
difference in affinity of these two SAGs for the commonSpeC interacts with both hV2.1 and hV4.1, stimulation
of human T cells bearing V2.1 is 15-fold greater than mV8.2 target, with which SpeA forms an approximately
20-fold tighter complex than SEB [24]. Alternatively, thethose presenting V4.1 domains [33]. The sequence of
hV4.1 includes the Ser52a-inserted residue in its CDR2 higher affinity of SpeA for mV8.2 may derive, at least
in part, from its interaction with the CDR1 loop.loop but lacks the hV2.1-like insertion in CDR1. Other
V domains that have the CDR1 insertion but lack the Interestingly, SpeA also stimulates human T cells
bearing V2.1 domains [38, 39]. It is unlikely that SpeAone in CDR2, such as hV20.1, are not recognized by
SpeC. Thus, of these two rare insertions, the CDR2 inser- binds hV2.1 in a manner analogous to SpeC, as none
of the SpeC residues identified in the interface with thistion may confer SAG binding specificity, while the CDR1
insertion may be responsible for increased affinity. V are conserved in SpeA. It may be even less likely
that SpeA binding to hV2.1 involves the same bindingThe extended conformation of the hV2.1 CDR3 loop
results in several specific intermolecular contacts with mode observed in its complex with mV8.2. First, much
of the V domain surface that forms the interface withSpeC (Figures 3A and 4). The hV2.1 CDR3 residues in
contact with SpeC derive from V-D-J recombination SpeA in mV8.2 is dramatically altered in hV2.1, largely
due to the two amino acid insertions in CDR1 and CDR2and, thus, are not present in all human V domains. As
no structure of this TCR  chain exists in its uncom- discussed above. Second, when recombinant wild-type
SpeA and a panel of mutants were tested for the abilityplexed form, it is impossible to determine whether this
is simply a serendipitous interaction due to the flexibility to stimulate hV2.1-positive T cells [39], there was no
correlation between the effect of specific mutations andof the CDR3 loop. Indeed, a model of a complex between
SEB and hV12.3 [2, 27] shows that CDR3 Leu98, also the SpeA residues that we have shown here to be in-
volved in binding mV8.2. Thus, it is most probable thatderived from V-D-J recombination, would be posi-
tioned close enough to SEB to form specific contacts. In the SpeA-hV2.1 complex will provide a binding mode
distinct from that seen for the SpeA-mV8.2 or SpeC-the -SpeA and -SEB complexes, the identical mV8.2
CDR3 loop has markedly different conformations (Fig- hV2.1 interactions. Human V2.1 is also the exclusive
target of TSST-1 [4]. Like SpeA, TSST-1 shares littleures 3B and 3C). Furthermore, flexibility of TCR CDR3
loops is not uncommon and has been proposed to be sequence homology with SpeC, and its as yet undeter-
mined complex with hV2.1 may represent still anotherimportant in TCR recognition of peptide/MHC com-
plexes [28]. It may be that protein plasticity in the V SAG binding mode to this V domain.
With this more diverse range of SAG-TCR interactionsdomain is also important in SAG recognition. While the
-SpeC complex described here represents the first now characterized on the structural level, we can begin
to observe a new paradigm for the selectivity of T cellstructural example of CDR3 involvement in SAG binding,
VCDR3 residues have been reported to influence T cell activation by SAGs, depending on varying levels of V
domain specificity. One group of highly promiscuousreactivity toward other microbial SAGs, namely Myco-
plasma arthritidis mitogen (MAM) [36] and mouse ret- T cell activators, including SEB and SEC3, binds TCR
 chains in the simple conformation-dependent mannerroviral Mtv-9 SAG (vSAG9) [37]. Although this precludes
the -SpeA or -SEB binding mode for MAM and vSAG9 described above and interacts with only a single CDR
loop, CDR2. Moderately promiscuous T cell activators,interactions with their respective TCR  chain ligands,
there also exists no evidence that these SAGs utilize the including SpeA, can be grouped together on the basis
Structure
696
of their dependence on numerous specific interactions and stimulate a very large fraction of all T cells, while
others are much more restricted in TCR binding andmediated by direct side chain to side chain contacts
overlayed onto the conformation dependence of the first T cell activation. Although the number of SAG-TCR com-
plex structures is still quite low, the limited availablegroup and the additional involvement of the CDR1 loop.
A third group of highly selective T cell activators, includ- database has allowed the identification of some correla-
tions between the V domain specificity of SAGs anding SpeC, binds those TCR V domains that have the
highest degree of structural dissimilarity, including non- certain structural characteristics of the V domain hy-
pervariable regions that they bind. Currently, the struc-canonical CDR loop conformations and residue inser-
tions as well as usage of all three CDR loops, incorporat- tures of two SAGs, SEB and SpeC, have been deter-
mined in complex with both of their respective MHC anding the highly variable CDR3 loop. TSST-1, which
activates only human T cells bearing V2.1 domains, TCR binding partners, allowing comparison of structural
models of the SEB- and SpeC-dependent MHC-SAG-may be the most extreme example in this third selectivity
group. TCR complexes. The MHC-SEB-TCR signaling complex
is dependent on low-affinity interactions between SAG-Even though TCR is engaged very differently in TCR-
MHC, TCR-SEB/SEC-MHC, and TCR-SpeC-MHC com- MHC and SAG-TCR as well as a direct MHC-TCR inter-
face. This results in overall ternary complex stability thatplexes, it is remarkable that the end result—highly efficient
T cell activation—is very similar. This strongly implies is similar to those for peptide/MHC-TCR complexes.
SpeC abrogates all direct contacts between MHC andthat the specific geometry of TCR ligation may be less
critical than other factors, such as the affinity and kinet- TCR molecules in the MHC-SpeC-TCR complex, whose
stability relies on a high-affinity interaction betweenics of the binding reaction, in triggering T cells. Indeed,
we have previously shown that the half-life of the TCR- SpeC and MHC and a low-affinity interaction between
SpeC and TCR. While SEB and SpeC produce signifi-SEC3-MHC complex (8 s) [30] falls within the range
measured for specific TCR-peptide/MHC complexes cantly different ternary T cell signaling complexes in
terms of their molecular architectures, they nevertheless(1–60 s) [40]. In this case, maximum stabilization is
achieved through direct TCR-MHC interactions that result in very similar T cell responses.
compensate for the weak individual affinities of SEC3
Experimental Proceduresfor TCR and MHC and increase the overall half-life of
the ternary signaling complex. Although we have not
Protein Expression and Purification
measured the half-life of the TCR-SpeC-MHC complex, Soluble, unglycosylated 14.3.d TCR  chain (mV8.2) was produced
we expect that it, too, will be comparable to those of as described previously [18]. The SpeA(C90S) and SpeC(H35A) mu-
TCR-peptide/MHC complexes. However, since direct tants were expressed in Escherichia coli BL21(DE3) as described
[35]. The SAGs were purified by successive preparative flatbed iso-TCR-MHC interactions are precluded in the TCR-SpeC-
electric focusing, using pH gradients of 3.5–10 and 6–8. SpeA(C90S)MHC complex, sufficient stabilization must be achieved
was further purified by ion exchange chromatography using a MonoQthrough the interplay of TCR-SAG and SAG-MHC inter-
anion exchange column (Pharmacia) equilibrated with 20 mM Tris-
actions alone. This suggests that the far higher affinity HCl (pH 8.5) developed with a linear NaCl gradient. Further purifica-
of the SpeC-MHC relative to the SEC3-MHC interaction tion of SpeC(H35A) was carried out by size exclusion chromatogra-
(KDs  4  108 M and 3  104 M, respectively) [13, phy on a Superdex 75 FPLC column (Pharmacia) equilibrated with
HBS. The gene encoding human V2.1D2.1J2.3C2, kindly pro-30] may circumvent the need for TCR-MHC contacts in
vided by U. Utz and R.-P. Se´kaly (University of Montreal), was clonedthe TCR-SpeC-MHC complex.
between the NdeI and EcoRI restriction sites of the pET17b expres-
sion vector (Novagen). Residues Cys13 and Cys191 of the mature
protein were mutated to Ala using the Quik Change Mutagenesis
Biological Implications Kit (Stratagene). Expression of hV2.1 was carried out in E. coli
BL21(RIL), and protein from inclusion body preparations was folded
Superantigens are potent immunomodulators, eliciting in vitro in 100 mM Tris-HCl (pH 8.5), 900 mM arginine-HCl, 100 mM
L-arginine, 2 mM EDTA, 6.3 mM cysteamine, and 3.7 mM cystamine.massive T cell proliferation through simultaneous inter-
Properly folded material was purified in two steps, first by sizeaction with MHC class II and TCR molecules. This can
exclusion chromatography using a Superdex 75 column equilibratedresult in the release of inordinate quantities of pyrogenic
in 25 mM Tris-HCl (pH 7.5) and 150 mM NaCl and subsequently by
and inflammatory cytokines, leading to disease. De- anion exchange chromatography using a MonoQ column equili-
termining the structural basis for the T cell stimulatory brated in 20 mM Tris-HCl (pH 8.5) developed using a linear NaCl
capabilities of SAGs is a key step in understanding SAG- gradient.
induced disease pathogenesis and the possible devel-
Crystallization and Data Collectionopment of effective therapeutics, a task that is made
Crystals of the SpeA(C90S)-mV8.2 complex were grown at roomdifficult due to the variability in the binding modes of
temperature in hanging drops by mixing 1 
l of complex solutionthe SAG to both its MHC and TCR binding partners.
(containing an equimolar ratio of mV8.2 and SpeA(C90S) at a total
While this binding variability has been well defined crys- protein concentration of 8 mg/mL) with an equal volume of reservoir
tallographically for SAG-MHC complexes, interaction solution containing 15% polyethylene glycol (PEG) 8000, 0.2 M
MgCl2, and 0.1 M Tris-HCl (pH 8.0). Crystals were washed threevariability and, subsequently, TCR V domain specificity
times with mother liquor and transferred to a cryoprotectant solutionin SAG-TCR complexes have not been nearly as well
(mother liquor containing 25% glycerol) prior to flash cooling inelucidated on the structural level. The SAG-TCR  chain
liquid propane. Crystals in the presence of zinc were prepared bystructures presented in this study have significantly in-
soaking the native crystals in 5 mM ZnCl2 for 6 hr prior to flashcreased our understanding of the structural basis for cooling. X-ray diffraction data were collected on an ADSC Quantum-4
T cell activation by SAGs. These structures show why CCD detector from a single complex crystal at 100 K on beamline
19-ID ( 0.978 A˚) of Argonne National Laboratory. The SpeA(C90S)-certain SAGs bind to a wide range of TCR V domains
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mV8.2 complex crystallized in space group P21 with cell dimen- model that included essentially all of one hV2.1 molecule, a second
V domain, and portions of the core region of the second C Igsions a 71.4 A˚, b 83.3 A˚, c 93.6 A˚, and  91.6 and diffracted
to a nominal resolution of 2.8 A˚. The zinc-soaked crystals were domain. Although four structurally equivalent -SpeC complexes
exist in the asymmetric unit, as evidenced by noncrystallographicessentially isomorphous, with cell dimensions a 71.7 A˚, b 83.7 A˚,
c  93.9 A˚, and   91.7, but diffracted to 2.5 A˚ resolution. Diffrac- symmetry, crystal packing constraints, and electron density, manual
fitting of any portion of the third or fourth TCR  chains did nottion data were processed and scaled using HKL2000/SCALEPACK
[41], and data reduction was completed using programs from the improve the overall refinement statistics and were therefore left
out of the final model. This also proved to maximize the data toCCP4 suite [42].
Crystals of SpeC(H35A)-hV2.1 were grown at room temperature parameters ratio, as inclusion of the poorly defined  chains pushed
this ratio to unacceptable levels. Refinement and model buildingin hanging drops by mixing 1 
l of complex solution (containing an
equimolar ratio of SpeC(H35A) and TCR  chain at a total protein was then carried out in a more conventional manner with iterative
cycles of positional, torsion angle, and B factor refinement, inter-concentration of 10 mg/ml) with an equal volume of reservoir solu-
tion containing 5% PEG 6000, 0.1 M LiCl, and 0.1 M HEPES (pH 7.0). spersed with model rebuilding into A-weighted Fo  Fc, 2Fo  Fc,
and composite annealed omit electron density maps using XtalViewCrystals were washed prior to transfer to cryoprotectant solution
(mother liquor containing 20% ethylene glycol) and flash cooling in [46]. Only procedures that minimized Rfree were followed, and the
discrepancy between Rfree and Rcryst was kept as small as possible.liquid propane. Diffraction data were collected on an ADSC Quan-
tum-4 CCD detector on beamline F-1 (  0.943) at the Cornell Noncrystallographic restraints on the four SpeC molecules were
relaxed and eventually eliminated throughout the refinement, con-High Energy Synchrotron Source. The SpeC(H35A)-hV2.1 complex
crystallized in space group P21 with cell dimensions of a  57.4 A˚, comitant with obvious differences in electron density for multiple
regions of the four SpeC molecules and a decrease in Rfree values.b  146.9 A˚, c  136.0 A˚, and   98.7 and diffracted to a nominal
resolution of 3.0 A˚. Diffraction data were processed and scaled Due to the relatively low resolution of the structure, no water mole-
cules were built into the model. The region of the crystal involvedusing DENZO and SCALEPACK [41], and data reduction was com-
pleted using programs from the CCP4 suite [42]. Data collection in the interaction between SpeC and the first TCR  chain molecule
appears to be the most ordered, as reflected by the lower meanstatistics for all of the complex structures are shown in Table 1.
temperature (B) factors (Table 1); disorder increases as the distance
from the interface becomes greater, with the second C domainStructure Determination and Refinement
displaying the highest mean B factor. The majority of missing resi-The structure of the zinc-soaked SpeA(C90S)-mV8.2 complex was
dues in the model are either from chain termini, the poorly orderedsolved by molecular replacement methods using the program
second C domain, or the missing third and fourth TCR  chains.AMoRe [43], with crystal structures of SpeA (PDB ID code 1B1Z)
Current refinement statistics for all of the complex structures areand the 14.3.d TCR  chain (PDB ID code 1BEC) as search models.
summarized in Table 1. Figures were produced with Molscript [47],The solution for SpeA was found first, and its position was fixed in
Bobscript [48], Raster3D [49], and GRASP [50].order to locate the TCR  chain with the phased translation function
calculation. The initial model solutions gave a correlation coefficient
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